Chronic neuropathic pain: mechanisms, drug targets and measurement

被引:91
|
作者
Finnerup, Nanna B. [1 ]
Sindrup, Soren H.
Jensen, Troels S.
机构
[1] Aarhus Univ Hosp, Dept Neurol, Danish Pain Res Ctr, DK-8000 Aarhus, Denmark
[2] Odense Univ Hosp, Dept Neurol, DK-5000 Odense, Denmark
关键词
measurement; neuropathic pain; treatment;
D O I
10.1111/j.1472-8206.2007.00474.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuropathic pain is common in many diseases or injuries of the peripheral or central nervous system, and has a substantial impact on quality of life and mood. Lesions of the nervous system may lead to potentially irreversible changes and imbalance between excitatory and inhibitory systems. Preclinical research provides several promising targets for treatment such as sodium and calcium channels, glutamate receptors, monoamines and neurotrophic factors; however, treatment is often insufficient. A mechanism-based treatment approach is suggested to improve treatment. Valid and reliable tools to assess various symptoms and signs in neuropathic pain and knowledge of drug mechanisms are prerequisites for pursuing this approach. The present review summarizes mechanisms of neuropathic pain, targets of currently used drugs, and measures used in neuropathic pain trials.
引用
收藏
页码:129 / 136
页数:8
相关论文
共 50 条
  • [1] Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain
    Bravo, Lidia
    Llorca-Torralba, Meritxell
    Berrocoso, Esther
    Antonio Mico, Juan
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [2] Chronic neuropathic pain: Mechanisms and treatment
    Attal, N
    CLINICAL JOURNAL OF PAIN, 2000, 16 (03) : S118 - S130
  • [3] Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications
    Patel, Sneh
    Mittal, Rhiya
    Sarantopoulos, Konstantinos D.
    Galor, Anat
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (08) : 681 - 695
  • [4] Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
    Bernatoniene, Jurga
    Sciupokas, Arunas
    Kopustinskiene, Dalia Marija
    Petrikonis, Kestutis
    PHARMACEUTICS, 2023, 15 (07)
  • [5] Identifying molecular mechanisms of acute to chronic pain transition and potential drug targets
    Aravagiri, Kannan
    Ali, Adam
    Wang, Hank C.
    Candido, Kenneth D.
    Knezevic, Nebojsa Nick
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2022, 26 (09) : 801 - 810
  • [6] Research progress of mechanisms and drug therapy for neuropathic pain
    Yan, Yun-yi
    Li, Cheng-yuan
    Zhou, Lin
    Ao, Lu-yao
    Fang, Wei-rong
    Li, Yun-man
    LIFE SCIENCES, 2017, 190 : 68 - 77
  • [7] BDNF as a biomarker for neuropathic pain: Consideration of mechanisms of action and associated measurement challenges
    Thakkar, Bhushan
    Acevedo, Edmund O.
    BRAIN AND BEHAVIOR, 2023, 13 (03):
  • [8] Neuropathic pain: Mechanisms, diagnosis and treatment
    Yucel, Aysen
    Cimen, Ali
    AGRI-THE JOURNAL OF THE TURKISH SOCIETY OF ALGOLOGY, 2005, 17 (01): : 5 - 13
  • [9] Mechanisms of neuropathic pain
    Nickel, Florian T.
    Seifert, Frank
    Lanz, Stefan
    Maihoefner, Christian
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (02) : 81 - 91
  • [10] Mechanisms of neuropathic pain
    Jänig, W
    NERVENHEILKUNDE, 2004, 23 (05) : 251 - +